As Donald Trump prepares to retake his seat at the Resolute Desk, Robert F. Kennedy Jr. has positioned himself to wield sweeping influence over US health care from day one of a new Trump administration.
It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but investors in vaccine stocks are already taking cover. Stocks of vaccine-makers were underperforming on Wednesday,
RFK Jr.’s sister, Kerry Kennedy, explains why she doesn’t trust her brother to run a health agency in the US and issues a warning about President-elect Donald Trump.
Projected winner of the presidential election former President Donald Trump vowed, even on Election Day, to give Robert F. Kennedy Jr. a significant role in health care under his new administration.
Robert F. Kennedy Jr., who may play a key role in overseeing health care in a second Trump administration, spoke to NBC News’ Vaughn Hillyard about his current views on vaccines, fluoride in water, and more.
With Donald Trump’s victory in the presidential election, public health experts are anxiously waiting to see whether his embrace of Robert F. Kennedy Jr. will translate into real policy, and perhaps chaos, at the Food and Drug Administration — the regulator tasked with ensuring that America’s drugs are effective and its food is safe to eat.